{"id":"https://openalex.org/W1998807248","doi":"https://doi.org/10.1002/art.30119","title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","display_name":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","publication_year":2010,"publication_date":"2010-10-27","ids":{"openalex":"https://openalex.org/W1998807248","doi":"https://doi.org/10.1002/art.30119","mag":"1998807248","pmid":"https://pubmed.ncbi.nlm.nih.gov/21279998"},"language":"en","primary_location":{"id":"doi:10.1002/art.30119","doi":"https://doi.org/10.1002/art.30119","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.30119","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis &amp; Rheumatism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061552694","display_name":"Lisa K. Stamp","orcid":"https://orcid.org/0000-0003-0138-2912","observed_orcids":["https://orcid.org/0000-0003-0138-2912"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Lisa K. Stamp","raw_affiliation_strings":["University of Otago, Christchurch, New Zealand. lisa.stamp@cdhb.govt.nz","University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago, Christchurch, New Zealand. lisa.stamp@cdhb.govt.nz","institution_ids":["https://openalex.org/I80281795"]},{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003277036","display_name":"John Liston O'Donnell","orcid":"https://orcid.org/0000-0002-3425-4805","observed_orcids":["https://orcid.org/0000-0002-3425-4805"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"John L. O'Donnell","raw_affiliation_strings":["University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115592399","display_name":"Mei Zhang","orcid":"https://orcid.org/0000-0003-2717-7167","observed_orcids":["https://orcid.org/0000-0003-2717-7167","https://orcid.org/0009-0005-6381-6220"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Mei Zhang","raw_affiliation_strings":["University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102047417","display_name":"Jill James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Jill James","raw_affiliation_strings":["University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111095783","display_name":"CHRISTOPHER M. A. FRAMPTON","orcid":"https://orcid.org/0000-0003-0603-5661","observed_orcids":["https://orcid.org/0000-0003-0603-5661"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Christopher Frampton","raw_affiliation_strings":["University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034417886","display_name":"Murray L. Barclay","orcid":"https://orcid.org/0000-0003-2944-8338","observed_orcids":["https://orcid.org/0000-0003-2944-8338"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Murray L. Barclay","raw_affiliation_strings":["University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012664051","display_name":"Peter T. Chapman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Peter T. Chapman","raw_affiliation_strings":["University of Otago Christchurch New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Christchurch New Zealand","institution_ids":["https://openalex.org/I80281795"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I80281795"],"apc_list":null,"apc_paid":null,"fwci":14.2151,"has_fulltext":false,"cited_by_count":237,"citation_normalized_percentile":{"value":0.99144785,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"63","issue":"2","first_page":"412","last_page":"421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/chronic-gout","display_name":"chronic gout","score":0.9620000123977661},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.7300000190734863},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8240000009536743},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.9269999861717224},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":0.8429999947547913},{"id":"https://openalex.org/keywords/oxypurinol","display_name":"oxypurinol","score":0.9490000009536743},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6150000095367432},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4830000102519989},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.41999998688697815},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5429999828338623},{"id":"https://openalex.org/keywords/urate-lowering-therapy","display_name":"urate-lowering therapy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.6290000081062317},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.5040000081062317},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.35199999809265137},{"id":"https://openalex.org/keywords/gout-flares","display_name":"gout flares","score":0.3499999940395355}],"concepts":[{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.9839629530906677},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.9024443626403809},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8908745050430298},{"id":"https://openalex.org/C176674119","wikidata":"https://www.wikidata.org/wiki/Q11582","display_name":"Liter","level":2,"score":0.8669607639312744},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.7256577014923096},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.55573570728302},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5055680274963379},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5006167888641357},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.4870803654193878},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.48012518882751465},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43373411893844604},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3858717679977417}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000493","descriptor_name":"Allopurinol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/art.30119","doi":"https://doi.org/10.1002/art.30119","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.30119","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis &amp; Rheumatism","raw_type":"journal-article"},{"id":"pmid:21279998","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21279998","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis and rheumatism","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W1864638351","https://openalex.org/W1963805301","https://openalex.org/W1964410175","https://openalex.org/W1965212373","https://openalex.org/W1971923348","https://openalex.org/W1986305152","https://openalex.org/W1990212288","https://openalex.org/W2000166571","https://openalex.org/W2002915215","https://openalex.org/W2022503135","https://openalex.org/W2023366539","https://openalex.org/W2037644412","https://openalex.org/W2039195112","https://openalex.org/W2044334793","https://openalex.org/W2049621329","https://openalex.org/W2078467670","https://openalex.org/W2083508836","https://openalex.org/W2098144815","https://openalex.org/W2102351697","https://openalex.org/W2113596992","https://openalex.org/W2122412537","https://openalex.org/W2124187588","https://openalex.org/W2136052345","https://openalex.org/W2151809600","https://openalex.org/W2165447689","https://openalex.org/W2167491049","https://openalex.org/W2171243007","https://openalex.org/W2274198535","https://openalex.org/W2418296477"],"related_works":["https://openalex.org/W2093489038","https://openalex.org/W2748095637","https://openalex.org/W1864638351","https://openalex.org/W2779654189","https://openalex.org/W2595336675","https://openalex.org/W2136052345","https://openalex.org/W4408571084","https://openalex.org/W2073862257","https://openalex.org/W2012551445","https://openalex.org/W1981242698"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"the":[3,9,13,49,64,91,98,104,116,145,195,197,209,236,247,295,308,313,324],"efficacy":[4],"and":[5,75,127,144,159],"safety":[6],"of":[7,33,43,54,93,115,130,140,147,190,208,224,251,275,291,310,330,337,352],"increasing":[8],"allopurinol":[10,34,44,94,148,161,230,244,292,311],"dose":[11,17,32,42,146,165,185,290,309,317],"above":[12,246,312],"proposed":[14,314],"creatinine":[15,315],"clearance-based":[16,316],"in":[18,151,156,169,235,323,347],"patients":[19,109,117,134,173,192,211,253,331,348],"with":[20,24,229,356],"gout.":[21],"METHODS:":[22],"Patients":[23,59,284],"gout":[25],"who":[26,193,212],"had":[27,135,213,221],"been":[28],"receiving":[29,255,258,267,285,349],"a":[30,136,214,271,288,320,333],"stable":[31],"for":[35,71,82,242],"\u2265":[36,141,218],"1":[37],"month":[38],"were":[39,60,77,88,110,125,129,174,254,260,304],"recruited.":[40],"The":[41,112],"was":[45,68,118,149,162,167,201,240,344],"increased":[46,150,346],"to":[47,176,269,293,319],"obtain":[48],"target":[50,296],"serum":[51,65,137,198,215,237,272,297,325,334],"urate":[52,66,138,199,216,238,273,298,326,335],"level":[53,200,217],"<0.36":[55,69,202,276,338],"mmoles/liter":[56,70,203,220,277],"(<6":[57],"mg/dl).":[58],"seen":[61,78],"monthly":[62],"until":[63],"concentration":[67,139,239,274,336],"3":[72,80,157],"consecutive":[73],"months":[74,81],"then":[76],"every":[79],"at":[83,204],"least":[84],"12":[85,205],"months.":[86,206],"Data":[87],"analyzed":[89],"using":[90],"dosage":[92],"(mg/day)":[95],"greater":[96],"than":[97],"recommended":[99,248],"dosage,":[100],"as":[101,262,264],"defined":[102],"by":[103],"Hande":[105],"criteria.":[106],"RESULTS:":[107],"Ninety":[108],"enrolled.":[111],"mean":[113],"age":[114],"58.7":[119],"years":[120],"(range":[121],"27-83":[122],"years),":[123],"87.9%":[124],"male,":[126],"81.9%":[128],"European":[131],"ancestry.":[132],"Forty-five":[133],"0.36":[142,219],"mmoles/liter,":[143],"these":[152,170],"patients.":[153,171],"Rashes":[154],"developed":[155,179],"patients,":[158],"either":[160],"discontinued":[163],"or":[164,178],"escalation":[166],"ceased":[168],"Seven":[172],"lost":[175],"followup":[177],"intervening":[180],"medical":[181],"problems":[182],"that":[183],"precluded":[184],"escalation.":[186],"In":[187,340],"31":[188],"(88.8%)":[189],"35":[191],"completed":[194],"study,":[196],"Two":[207],"5":[210],"undetectable":[222],"levels":[223],"plasma":[225],"oxypurinol,":[226],"indicating":[227],"noncompliance":[228],"treatment.":[231],"A":[232],"significant":[233,321],"reduction":[234,322],"observed":[241],"all":[243],"doses":[245,351],"dose.":[249],"Eighteen":[250],"45":[252],"furosemide;":[256],"those":[257,265,355],"furosemide":[259,268,286],"just":[261],"likely":[263],"not":[266,345],"achieve":[270,294],"(72%":[278],"versus":[279],"88.5%;":[280],"P":[281],"=":[282],"0.24).":[283],"required":[287],"higher":[289,350],"concentration.":[299,327],"No":[300],"serious":[301],"adverse":[302],"events":[303],"observed.":[305],"CONCLUSION:":[306],"Increasing":[307],"led":[318],"Approximately":[328],"89%":[329],"achieved":[332],"mmoles/liter.":[339],"this":[341],"cohort,":[342],"toxicity":[343],"allopurinol,":[353],"including":[354],"renal":[357],"impairment.":[358]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":21},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":18},{"year":2012,"cited_by_count":26}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}